๐ฐ Product Testing News
Page 28 - Product Testing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Product Testing. Real-time updates on events, politics, business and more.
March 16, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. PCI Pharma Broadens Clinical Trial Service Offerings at Berlin Facility, Bringing Worldwide Access to Clients in the European Union March 16, 2021 GMT PCI has added significant capacity and several new cold chain storage conditions to its Berlin facility, which now includes temperatures from controlled room temperature to -80ยฐC. The Berlin facility is now congruent with all PCI global facilities, help...
March 16, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation. Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer March 16, 2021 GMT Not intended for UK-based media DARMSTADT, Germany, March 16, 2021 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa ...
March 16, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation. Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results March 16, 2021 GMT RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second ... RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TS...
March 16, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation. LabConnect Announces Major Clinical Trial Kit Facility Expansion March 16, 2021 GMT (PRNewsfoto/LabConnect) JOHNSON CITY, Tenn., March 16, 2021 /PRNewswire/ -- LabConnect, a leading global provider of central laboratory and support services for the biopharmaceutical industry, today announced a major expansion of its Johnson City facility. In response to unprecedented demand for LabConnectโs services fo...
March 16, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. Merck Receives Priority Review From FDA for New Drug Application for HIF-2ฮฑ Inhibitor Belzutifan (MK-6482) March 16, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Mar 16, 2021-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a New Drug Application (NDA) for the hypoxia-ind...
March 16, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 15, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation. 9 Meters Biopharma Hosting Key Opinion Leader Webinar on Short Bowel Syndrome and NM-002 Program Update March 15, 2021 GMT Tuesday, March 23rd @ 11am Eastern Time RALEIGH, NC / ACCESSWIRE / March 15, 2021 / 9 Meters Biopharma (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, today announced that it will host a key opinion leader (KOL) webinar on short bowel syndrome (S...
March 15, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. OSE Immunotherapeutics and ARCAGY - GINECO Announce Initiation of a Randomized Phase 2 Clinical ... OSE ImmunotherapeuticsMarch 15, 2021 GMT This clinical trial will be sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and OSE Immunotherapeutics. The study will explore Ted...
March 15, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation. VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D March 15, 2021 GMT Logo of VLP Therapeutics GAITHERSBURG, Md., March 15, 2021 /PRNewswire/ -- US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on March 15 that it has raised US$16 million in a Series A funding round from MIYAKO Capital Co., Ltd., Sojitz Corporation, Konishiyasu Co., Ltd., in Japan and three existing in...
March 15, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.